Louis J. Lavigne Jr.
Director, Allergan plc.
Companies
- Alector (United States)Board member Feb 6, 2019 to now1
- ZyngaBoard member Apr 27, 2015 to May 24, 20222
- ACCURAY INCBoard member Sep 14, 2009 to Dec 2, 20203
- DocusignBoard member Apr 26, 2018 to Jun 19, 20194
- NovoCure LtdBoard member Oct 1, 2015 to Jun 4, 20185
- Allergan plcBoard member May 3, 2006 to Mar 19, 20156
- Arena PharmaceuticalsBoard member Aug 1, 2006 to Aug 1, 20067
- EquinixBoard member Jun 9, 2006 to Jun 9, 20068
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Alector (United States) ALEC138,661 shares9$268.3K at $1.94Jun 17, 2026
Zynga ZNGA0 shares10May 23, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 17, 2026Granted 28,700 shares of Alector (United States)9
- Jun 11, 2025Granted 28,700 shares of Alector (United States)11
- Jun 12, 2024Granted 35,000 shares of Alector (United States)12
- Jun 14, 2023Granted 26,250 shares of Alector (United States)13
- Jun 16, 2022Granted 9,459 shares of Alector (United States)14
- May 23, 2022Returned to company 278,516 shares of Zynga10
- May 23, 2022Returned to company 5,548 shares of Zynga10
- May 17, 2022Exercised options 5,548 shares of Zynga15
- Feb 17, 2022Exercised options 5,547 shares of Zynga16
- Nov 17, 2021Exercised options 5,547 shares of Zynga17
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARZynga, Board member
- 3SEC EDGARACCURAY INC, Board member
- 4SEC EDGARDocusign, Board member
- 5SEC EDGARNovoCure Ltd, Board member
- 6SEC EDGARAllergan plc, Board member
- 7SEC EDGARArena Pharmaceuticals, Board member
- 8SEC EDGAREquinix, Board member
- 9
- 10
- 11SEC EDGARForm 4 filed Jun 12, 2025
- 12SEC EDGARForm 4 filed Jun 12, 2024
- 13SEC EDGARForm 4 filed Jun 15, 2023
- 14SEC EDGARForm 4 filed Jun 21, 2022
- 15SEC EDGARForm 4 filed May 19, 2022
- 16SEC EDGARForm 4 filed Feb 22, 2022
- 17SEC EDGARForm 4 filed Nov 17, 2021